| Type | MGI:General | Description | in an IPA model of allogeneic, T-cell-depleted bone marrow transplantation, combined systemic and local PTX3 administration results in a 2-fold increase in survival time with 2 of 8 homozygotes being cured, along with a >4-fold reduction in lung CFU counts |
